Insider Title Company Date Price Return Shares Value
Giordano Christopher Thomas CEO TENAX THERAPEUTICS, INC. (TENX) 2025-11-20 $7.68 0.0% 2,605 $20,000
Return Profit / (loss) Cost
Total 0.0% $0 $20,000